Sirolimus-Eluting versus Bare Stents after Suboptimal Infrapopliteal Angioplasty for Critical Limb Ischemia: Enduring 1-Year Angiographic and Clinical Benefit

Abstract

Purpose:

To report the 1-year angiographic and clinical outcome from a prospective single-center study investigating the infrapopliteal application of sirolimus-eluting versus bare metal stents in patients with critical limb ischemia (CLI) who underwent below-the-knee endovascular revascularization.

Methods:

Stenting was performed as a bailout procedure for suboptimal angioplasty results (flow-limiting dissection, elastic recoil, or postangioplasty residual stenosis >30%). In the first 29 patients, infrapopliteal stenting was performed with bare metal stents (group B) and with sirolimus-eluting stents in the other 29 patients (group S).

Results:

Below-the-knee angioplasty and stenting involved 65 lesions in 40 infrapopliteal arteries of 29 limbs in group B and 66 lesions in 41 infrapopliteal arteries of 29 limbs in group S. Baseline comorbidities (hyperlipidemia and symptomatic cardiac and carotid disease) were more pronounced in group S (p<0.05). At 6 months, sirolimus-eluting stents demonstrated significantly higher primary patency (OR 5.625, 95% CI 1.711 to 18.493, p=0.004) and decreased in-stent binary restenosis (OR 0.067, 95% CI 0.021 to 0.017, p<0.001) and in-segment binary restenosis (OR 0.229, 95% CI 0.099 to 0.533, p=0.001). After 1 year, sirolimus-eluting stents were steadily associated with increased primary patency (OR 10.401, 95% CI 3.425 to 31.589, p<0.001) and significantly less in-stent (OR 0.156, 95% CI 0.060 to 0.407, p<0.001) and in-segment (OR 0.089, 95% CI 0.023 to 0.349, p=0.001) binary restenosis. In addition, sirolimus-eluting stents were associated with significantly fewer cumulative target lesion reinterventions at 6 months (OR 0.057, 95% CI 0.008 to 0.426, p=0.005) and 1 year (OR 0.238, 95% CI 0.067 to 0.841, p=0.026). No significant differences between groups B and S were noted at 1 year with respect to mortality (10.3% versus 13.8%, respectively), minor amputation (17.2% versus 10.3%), or limb salvage (100% versus 96%).

Conclusion:

The application of sirolimus-eluting stents reduces the restenosis rate in the infrapopliteal arteries and the rate of repeat endovascular procedures the first year after treatment.

Keywords

critical limb ischemia infrapopliteal arteries balloon angioplasty sirolimus-eluting stents bare stents neointimal hyperplasia restenosis

Get full access to this article

View all access options for this article.

References

Dormandy

Rutherford

. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31(1 Pt 2): S1–S296.

Hirsch

Haskal

Hertzer

. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)–summary of recommendations. J Vasc Interv Radiol. 2006; 17: 1383–1397.

Rastogi

Stavropoulos

. Infrapopliteal angioplasty. Tech Vasc Interv Radiol. 2004; 7: 33–39.

Spinosa

Leung

Matsumoto

. Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia. Radiology. 2004; 232: 499–507.

Ballard

Mills

. Surgical management of critical limb ischemia. Tech Vasc Interv Radiol. 2005; 8: 169–174.

Chew

Conte

Donaldson

. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction. J Vasc Surg. 2001; 33: 259–265.

Faries

Arora

Pomposelli

. The use of arm vein in lower-extremity revascularization: Results of 520 procedures performed in eight years. J Vasc Surg. 2000; 31: 50–59.

Halloran

Lilly

Cohn

. Tibial bypass using complex autologous conduit: Patency and limb salvage. Ann Vasc Surg. 2001; 15: 634–643.

Wagner

Rager

. Infrapopliteal angioplasty: A forgotten region? [in German]. Rofo. 1998; 168: 415–420.

10.

Nasr

McCarthy

Hardman

. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2002; 23: 398–403.

11.

Rand

Basile

Cejna

. PTA versus carbofilm-coated stents in infrapopliteal arteries: Pilot study. Cardiovasc Intervent Radiol. 2006; 29: 29–38.

12.

Schillinger

Exner

Mlekusch

. Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. Radiology. 2003; 227: 419–425.

13.

Siablis

Kraniotis

Karnabatidis

. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther. 2005; 12: 685–695.

14.

Soder

Manninen

Jaakkola

. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: Angiographic and clinical results. J Vasc Interv Radiol. 2000; 11: 1021–1031.

15.

Tsetis

Belli

. The role of infrapopliteal angioplasty. Br J Radiol. 2004; 77: 1007–1015.

16.

Scheinert

Ulrich

Scheinert

. Comparison of sirolimus-eluting vs bare-metal stents for the treatment of infrapopliteal obstructions. Eurointervention. 2006; 2: 169–174.

17.

Feiring

Wesolowski

Lade

. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: Early and one-year outcomes. J Am Coll Cardiol. 2004; 44: 2307–2314.

18.

Krankenberg

Sorge

Zeller

. Percutaneous transluminal angioplasty of infrapopliteal arteries in patients with intermittent claudication: Acute and one-year results. Catheter Cardiovasc Interv. 2005; 64: 12–17.

19.

Morice

Serruys

Sousa

. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346: 1773–1780.

20.

Moses

Leon

Popma

. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349: 1315–1323.

21.

Schofer

Schluter

Gershlick

. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003; 362: 1093–1099.

22.

Serruys

Kutryk

Ong

. Coronary-artery stents. N Engl J Med. 2006; 354: 483–495.

23.

Sousa

Costa

Abizaid

. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation. 2001; 104: 2007–2011.

24.

Bosiers

Deloose

Verbist

. Percutaneous transluminal angioplasty for treatment of “below-the-knee” critical limb ischemia: Early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg (Torino). 2006; 47: 171–176.

25.

Commeau

Barragan

Roquebert

. Sirolimus for below the knee lesions: Midterm results of SiroBTK study. Catheter Cardiovasc Interv. 2006; 68: 793–798.

26.

Sacks

Marinelli

Martin

. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol. 2003; 14(9 Pt 2): S395–404.

27.

Bakal

Sprayregen

Scheinbaum

. Percutaneous transluminal angioplasty of the infrapopliteal arteries: Results in 53 patients. AJR Am J Roentgenol. 1990; 154: 171–174.

28.

Ansel

Sample

Botti

. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv. 2004; 61: 1–4.

29.

Peeters

Bosiers

Verbist

. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther. 2005; 12: 1–5.

30.

Vraux

Hammer

Verhelst

. Sub-intimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: Midterm results. Eur J Vasc Endovasc Surg. 2000; 20: 441–446.

31.

Dormandy

Heeck

Vig

. Acute limb ischemia. Semin Vasc Surg. 1999; 12: 148–153.

32.

McDaniel

Cronenwett

. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989; 3: 273–277.

33.

Aulivola

Gargiulo

Bessoni

. Infrapopliteal angioplasty for limb salvage in the setting of renal failure: Do results justify its use? Ann Vasc Surg. 2005; 19: 762–768.

34.

Brosi

Baumgartner

Silvestro

. Below-the-knee angioplasty in patients with end-stage renal disease. J Endovasc Ther. 2005; 12: 704–713.

35.

Schampaert

Moses

Schofer

. Sirolimus-eluting stents at two years: A pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. Am J Cardiol. 2006; 98: 36–41.